Inhaled Medicines: Past, Present, and Future
Inhaled Medicines: Past, Present, and Future
Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.
Peer-reviewed research, clinical studies, and scientific papers related to eFlow® Technology and inhaled therapies.
Inhaled Medicines: Past, Present, and Future
Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD.
Deposition of Inhaled Levofloxacin in Cystic Fibrosis Lungs Assessed by Functional Respiratory Imaging.
Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial.
The Role of Suboptimal Concentrations of Nebulized Tobramycin in Driving Antimicrobial Resistance in Pseudomonas aeruginosa Isolates in Cystic Fibrosis.